Logo
x

Search

Subscribe Now

Proposed

Samsung Bioepis Initiates P-I Study of SB17 Proposed Biosimilar to Stelara (ustekinumab)

Samsung Bioepis Initiates P-I Study of SB17 Proposed Biosimilar to Stelara (ustekinumab)

  • March 2, 2021
Bio-Thera Solutions Reports the US FDA's Acceptance of BLA for BAT1706 (Proposed Biosimilar to Avastin)

Bio-Thera Solutions Reports the US FDA's Acceptance of BLA for BAT1706 (Proposed Biosimilar to Avastin)

  • January 29, 2021
Genentech Files Complaint Against Centus Over Proposed Bevacizumab Biosimilar

Genentech Files Complaint Against Centus Over Proposed Bevacizumab Biosimilar

  • November 19, 2020
Samsung Bioepis Presents Results of SB11 Proposed Biosimilar to Lucentis in P-III Study at the AAO 2020 Virtual

Samsung Bioepis Presents Results of SB11 Proposed Biosimilar to Lucentis in P-III Study at the AAO 2020 Virtual

  • November 11, 2020
Biocon and Mylan Report the US FDA Acceptance of BLA for Proposed Biosimilar of Avastin (bevacizumab)

Biocon and Mylan Report the US FDA Acceptance of BLA for Proposed Biosimilar of Avastin (bevacizumab)

  • March 9, 2020
The US FDA Released Draft Guidelines for Proposed Biosimilar or Proposed Interchangeable Biosimilars

The US FDA Released Draft Guidelines for Proposed Biosimilar or Proposed Interchangeable Biosimilars

  • February 7, 2020
Samsung Bioepis Initiates P-I Study of SB17 Proposed Biosimilar to Stelara (ustekinumab)

    Samsung Bioepis Initiates P-I Study of SB17 Proposed Biosimilar to Stelara (ustekinumab)

    • March 2, 2021
    Bio-Thera Solutions Reports the US FDA

      Bio-Thera Solutions Reports the US FDA's Acceptance of BLA for BAT1706 (Proposed Biosimilar to Avastin)

      • January 29, 2021
      Alvotech Reports the US FDA and EMA

        Alvotech Reports the US FDA and EMA's Acceptance of AVT02 Proposed Biosimilar to Humira (adalimumab)

        • November 20, 2020
        Genentech Files Complaint Against Centus Over Proposed Bevacizumab Biosimilar

          Genentech Files Complaint Against Centus Over Proposed Bevacizumab Biosimilar

          • November 19, 2020
          Samsung Bioepis Presents Results of SB11 Proposed Biosimilar to Lucentis in P-III Study at the AAO 2020 Virtual

            Samsung Bioepis Presents Results of SB11 Proposed Biosimilar to Lucentis in P-III Study at the AAO 2020 Virtual

            • November 11, 2020
            Revance and Mylan to Advance Development Program for a Proposed Biosimilar to BOTOX

              Revance and Mylan to Advance Development Program for a Proposed Biosimilar to BOTOX

              • June 2, 2020
              Image

              Incisive News in 3 Shots.

              Contact Us

              Our Information

              Follow Us

              Copyright © 2025 PharmaShots - All Rights Reserved.